Owens & Minor, Inc. (OMI) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
OMI Revenue Growth
Revenue Breakdown (FY 2025)
OMI's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
OMI Revenue Analysis (2014–2025)
As of May 8, 2026, Owens & Minor, Inc. (OMI) generated trailing twelve-month (TTM) revenue of $2.76 billion, reflecting significant decline in growth of -146.3% year-over-year. The most recent quarter (Q4 2025) recorded $-1,249,197,000 in revenue, down 279.2% sequentially.
Looking at the longer-term picture, OMI's 5-year compound annual growth rate (CAGR) stands at -20.1%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $10.70 billion in 2024.
Revenue diversification analysis shows OMI's business is primarily driven by Diabetes Product (57%), Product and Service, Other (21%), and Wound Care (14%). With over half of revenue concentrated in Diabetes Product, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including MCK (+12.4% YoY), CAH (+12.8% YoY), and HSIC (+4.0% YoY), OMI has underperformed the peer group in terms of revenue growth. Compare OMI vs MCK →
OMI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| OMICurrent | $2.8B | -146.3% | -20.1% | 1.0% | |
 MCK | $359.1B | +12.4% | +9.2% | 1.2% | |
 CAH | $222.6B | +12.8% | +7.8% | 1.0% | |
 HSIC | $13.2B | +4.0% | +5.4% | 5.7% | |
 MMSI | $1.5B | +11.2% | +9.5% | 12.2% | |
 AVNS | $701M | +3.9% | -0.4% | -8.8% |
OMI Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $2.76B | -74.2% | $0 | - | $27.5M | 1.0% |
| 2024 | $10.70B | +3.6% | $2.22B | 20.7% | $-207,769,000 | -1.9% |
| 2023 | $10.33B | +3.8% | $2.13B | 20.6% | $104.5M | 1.0% |
| 2022 | $9.96B | +1.7% | $1.83B | 18.3% | $142.9M | 1.4% |
| 2021 | $9.79B | +15.4% | $1.51B | 15.5% | $368.5M | 3.8% |
| 2020 | $8.48B | -7.9% | $1.28B | 15.1% | $204.1M | 2.4% |
| 2019 | $9.21B | -6.4% | $1.13B | 12.3% | $73.2M | 0.8% |
| 2018 | $9.84B | +5.6% | $1.37B | 13.9% | $-392,174,000 | -4.0% |
| 2017 | $9.32B | -4.2% | $1.17B | 12.6% | $89.3M | 1.0% |
| 2016 | $9.72B | -0.5% | $1.19B | 12.2% | $199.6M | 2.1% |
See OMI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OMI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OMI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOMI — Frequently Asked Questions
Quick answers to the most common questions about buying OMI stock.
Is OMI's revenue growth accelerating or slowing?
OMI revenue declined -146.3% year-over-year, contrasting with the 5-year CAGR of -20.1%. TTM revenue fell to $2.8B. This reverses the prior growth trend.
What is OMI's long-term revenue growth rate?
Owens & Minor, Inc.'s 5-year revenue CAGR of -20.1% reflects the variable expansion pattern. Current YoY growth of -146.3% is below this long-term average.
How is OMI's revenue distributed by segment?
OMI reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.